Express Scripts Reports Specialty Drug Spending Steadily Rising, And Pipelines Show More To Come
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Not only are specialty drugs “the fastest-growing segment of drug spend,” but the pharmacy benefits manager Express Scripts predicts that specialty drug spend will account for 40% of U.S. drug spend by 2014.